amyloid-related imaging abnormalities (ARIA)
GPTKB entity
Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medical condition
|
| gptkbp:abbreviation |
gptkb:ARIA
|
| gptkbp:associatedWith |
gptkb:Alzheimer's_disease
|
| gptkbp:characterizedBy |
gptkb:superficial_siderosis
edema microhemorrhages |
| gptkbp:detects |
MRI
|
| gptkbp:firstDescribed |
2010
|
| https://www.w3.org/2000/01/rdf-schema#label |
amyloid-related imaging abnormalities (ARIA)
|
| gptkbp:managedBy |
dose adjustment
symptomatic therapy treatment interruption |
| gptkbp:observedBy |
clinical trials of monoclonal antibodies
|
| gptkbp:relatedTo |
cerebral amyloid angiopathy
|
| gptkbp:riskFactor |
gptkb:ApoE4_genotype
anti-amyloid antibody therapy |
| gptkbp:subspecies |
gptkb:ARIA-E
gptkb:ARIA-H |
| gptkbp:symptom |
confusion
nausea headache seizures |
| gptkbp:bfsParent |
gptkb:Aduhelm
gptkb:Donanemab |
| gptkbp:bfsLayer |
6
|